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Abstract: Cyclin dependent kinase inhibitor 1c (Cdkn1c) is a maternally expressed imprinted gene with 
roles in embryonic development, post-natal metabolism and behaviour. Using mouse models with 
altered dosages of Cdkn1c, we have previously identified a role for the gene in promoting brown 
adipose tissue formation. Here, we use these transgenic mouse lines to model the loss of imprinting 
of Cdkn1c in adulthood. We demonstrate that only a two-fold increase in the expression of Cdkn1c 
during development is sufficient to protect against age-related weight gain in addition to glucose 
and insulin intolerance. Further to this, we show that the loss of imprinting of Cdkn1c protects 
against diet-induced obesity. Bisulphite sequencing was performed to test the stability of the two 
differentially methylated regions that regulate Cdkn1c imprinting, and both were found to be 
unaltered in aged or diet-challenged adipose tissue, despite drastic reductions in Cdkn1c 
expression. These data demonstrate a critical role for Cdkn1c in regulating adult adipose tissue, 
with modest changes in expression capable of protecting against both age and diet-induced obesity 
and metabolic syndrome, with a natural decline in Cdkn1c expression observed that may contribute 
to less healthy metabolic aging. Finally, we have observed a post-natal insensitivity of the imprint 
to environmental factors, in contrast to recent observations of an in utero sensitivity. 
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1. Introduction 
Genomic imprinting is a phenomenon of epigenetic gene regulation, whereby mono-allelic 
expression of a gene occurs, in a parent-of-origin specific manner in placental mammals and some 
plants [1,2]. Cyclin dependent kinase inhibitor 1c (Cdkn1c) is a maternally expressed imprinted gene 
found on the IC2 imprinting cluster on mouse chromosome 7 [3]. The gene functions both in limiting 
cell proliferation, primarily as a G1/S phase inhibitor [4,5], and in directing differentiation of certain 
select lineages. These include regulating the differentiation of skeletal muscle [6], amacrine cells in 
the retina [7], and the maintenance of adult quiescent neural stem cell populations [8,9]. Imprinted 
expression of Cdkn1c is achieved through two distinct differentially methylated regions (DMRs). A 
germline differentially methylated region termed KvDMR is located >200 kb upstream of Cdkn1c 
within the Kcnq1 gene, and this region acquires DNA methylation in the maternal germline in mice 
and humans to establish imprinted expression of an extensive genomic region on mouse distal 
chromosome 7/human chromosome 11p15, called the IC2 cluster [10–12]. The Cdkn1c somatic DMR 
(sDMR) is located at the 5′ terminus of the Cdkn1c coding region, and is required for silencing 
maintenance, as opposed to establishment, through methylation of the silent paternally inherited 
allele [13]. This region has been shown to only possess methylation in somatic tissue in vivo, 
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acquired during early embryonic development and after allelic expression is established [14–16]. 
Our recent work using an imaging-based model of Cdkn1c expression reported that the Cdkn1c 
sDMR is sensitive to gestational protein restriction, with offspring exposed to the diet found to have 
reduced embryonic and post-natal methylation at this region, with an accompanying loss of 
imprinting of Cdkn1c [17].  
Elevated expression of Cdkn1c has been implicated as a cause of two similar but distinct 
childhood growth restriction disorders, Silver–Russell (SRS) and IMAGe syndrome [18], while a 
loss-of-function of Cdkn1c is present in familial cases of the childhood overgrowth disorder 
Beckwith–Wiedemann syndrome [19]. In order to model SRS, our lab developed transgenic mouse 
lines carrying additional copies of Cdkn1c, on a bacterial artificial chromosome (BAC) spanning 
Cdkn1c and two other imprinted genes Phlda2 and Slc22a18. To distinguish between the effects of 
elevated Cdkn1c expression and the effect of increasing the dosage of the other two genes, we 
developed a transgenic line containing a modified version of this same BAC where Cdkn1c 
expression is disrupted by a β-galactosidase insertion [20,21]. These lines provide an alternative route 
for studying imprinted genes, focusing on dosage rather than gene function per se. Classical 
knockout models, used to study the gene function of imprinted genes, frequently present with high 
levels of lethality associated with heterozygous deletion models presenting as a phenotypic 
homozygous deletion, due to the mono-allelic expression [22]. Using the BAC transgenic lines, we 
have demonstrated a dosage-dependent fetal growth restriction due to elevated Cdkn1c [20], which 
was maintained post-natally and into early adulthood. Further to this, a new function of the gene in 
regulating brown adipose tissue formation was recently described by our group, with elevated 
markers of mitochondrial uncoupling also uncovered in the white adipose tissue [23]. In SRS, 
children are born small and fail to catch up, with excessive thinness being an additional 
characteristic. Some SRS children are also reported to be fussy eaters, which has been suggested to 
contribute to their failure to gain weight. However, we showed that young mice carrying an extra 
copy of Cdkn1c were also thin with little subcutaneous fat despite consuming similar calories to 
controls [23]. Some SRS children also have night sweats which could suggest dysfunctional 
thermoregulation, consistent with the increase in brown adipose tissue we observed in our mouse 
model [23].  
In this study, we further explored the impact of increased Cdkn1c dosage in adult mice, focusing 
on the predicted role for Cdkn1c in influencing adult weight gain through regulating the 
development of brown fat depots. Imprinted gene function has classically been thought to be 
predominantly restricted to regulating embryonic and placental development; however, recent work 
has highlighted important post-natal functions for this class of gene [23–25]. Therefore, further 
elucidation of both gene and imprint function, in adulthood, will enable a clearer understanding of 
this method of epigenetic gene regulation. 
2. Results 
We have previously reported that mice bearing one (Cdkn1cBACx1) or two copies (Cdkn1cBACx2) of 
a BAC spanning the Cdkn1c locus were significantly lighter than wild type (WT) litter mates at 10 
weeks of age, with relative increases in expression of Cdkn1c in white and brown adipose tissue [23]. 
This phenotype was attributed to excess Cdkn1c, causing jointly a fetal growth restriction phenotype 
that was not resolved post-natally and reduced white adipose tissue (WAT) stores due to elevated 
brown adipose tissue (BAT) formation. To further understand the effect of elevated Cdkn1c into 
adulthood, mice were aged to 1 year, co-housed with sex-matched WT littermates. Monthly 
weighing found significantly reduced weights in both male (Figure 1a) and female (Figure 1b) 
Cdkn1cBACx1 (light green) and Cdkn1cBACx2 (dark green) mice when compared to wild type (black). In 
fact, all four transgenic groups increased in weight by less than 3 g over this 6-month period, in 
contrast to an average 7.5 g increase in male, and 4.5 g increase in female WT. Glucose and insulin 
tolerance testing was performed on the male cohort at 1 year of age, and found a significantly 
improved clearance of glucose after challenge (Figure 1c) in both Cdkn1cBACx1 and Cdkn1cBACx2 lines, 
in addition to heightened response to insulin testing, compared to age-matched WT males (Figure 
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1d). White adipose deposits were weighed in culled mice and found to be significantly smaller in 
both males (Figure 1e) and females (Figure 1f), as a percentage of total body weight, in order to 
control for growth restriction. As had been observed in the whole-body weights (Figure 1a,b), this 
reduction was found to be dosage-dependent, with Cdkn1cBACx2 mice showing a greater reduction in 
fat pad weights when compared to Cdkn1cBACx1.  
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Figure 1. Increased Cdkn1c dosage protects against age-related metabolic disorder. (a) Adult 
whole-body weights. Both Cdkn1cBACx1 (single copy bacterial artificial chromosome (BAC), light 
green) and Cdkn1cBACx2 (double copy, dark green) transgenic males were significantly lighter than 
wild type (black) litter mates between 6 months and 1 year of age, in a dosage-dependent manner. 
Individual 12-month weights are displayed on the right-hand graph (n: WT 8, Cdkn1cBACx1 6, 
Cdkn1cBACx2 4), * p < 0.05, ** p < 0.01; (b) Cdkn1cBACx1 (light green) and Cdkn1cBACx2 (dark green) 
transgenic females were also found to be significantly lighter than wild type (black) litter mates 
between 6 months and 1 year of age. Individual 12-month weights are displayed on the right-hand 
graph (n: 9, 5, 4), * p <0 .05, ** p < 0.01; (c) Glucose tolerance testing of 1-year old males revealed an 
improved clearance of glucose challenge in both Cdkn1cBACx1 and Cdkn1cBACx2 lines when compared 
to wild type mice. (n: 8, 6, 4), * p < 0.05, ^ p < 0.05 (Cdkn1cBACx2 only); (d) Insulin tolerance testing of 
1-year old males revealed greater sensitivity to insulin in both Cdkn1cBACx1 and Cdkn1cBACx2 lines 
when compared to wild type mice, (n: 8, 6, 4), * p < 0.05; (e) Wet weight of white adipose tissue in 
1-year old males, as a percentage of total body weight. Mesenteric (M), epididymal (E) and 
retroperitoneal (R) depots were all found to be significantly smaller in Cdkn1cBACx1 and Cdkn1cBACx2 
males compared to wild type. (n: 8, 6, 4), * p < 0.05, ** p < 0.01, *** p < 0.001; (f) Wet weight of white 
adipose tissue in 1-year old females, as a percentage of total body weight. Mesenteric (M), 
peri-ovarian (P) and retroperitoneal (R) depots were all found to be significantly smaller in 
Cdkn1cBACx1 and Cdkn1cBACx2 males compared to wild type, in a dosage-dependent manner. (n: 9, 5, 
4). * p < 0.05, ** p < 0.01, *** p < 0.001. 
Following the observation that elevated Cdkn1c could protect against age-related metabolic 
syndrome, we challenged Cdkn1cBACx1 male mice and litter-matched WT controls with a high fat diet 
(58V8, TestDiet) from 10 weeks of age for 12 weeks. Cdkn1cBACx1 males were found to be highly 
resistant to weight gain during the dietary challenge (Figure 2a). The average weight gain was 12.4% 
of the original body weight (2.1 g) over the 12-week period in contrast to the average 41.2% (10.1 g) 
gained by wild type male controls. In this experiment, we also included a third transgenic line to 
isolate the contribution of Cdkn1c to this resistance against weight gain. This third line of mice called 
Cdkn1cBAC-LacZ carries one copy of the same BAC transgene but without over-expression of Cdkn1c. 
Any phenotypes observed in Cdkn1cBACx1 mice and Cdkn1cBACx2 mice that are absent in 
Cdkn1cBAC-LacZ mice must be due to elevated Cdkn1c. Cdkn1cBAC-LacZ male mice gained weight on the 
high fat diet with the same profile as WT controls (Figure 2b) demonstrating that this protection 
against weight gain was due to Cdkn1c alone. To explore the extent of this phenotype, glucose 
tolerance testing was performed on these animals, with Cdkn1cBACx1 males displaying significantly 
improved glucose clearance (Figure 2c), compared to wild type mice. Further to this, insulin 
tolerance testing revealed a heightened response to insulin challenge in Cdkn1cBACx1 males (Figure 
2d), correlating with the effects observed in aging animals (Figure 1c,d). 
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Figure 2. Increased Cdkn1c dosage protects against diet-induced obesity. (a) Cdkn1cBACx1 male mice 
(light green) were found to resist weight gain during a 12-week high fat diet challenge, while wild 
type (WT) (black) and Cdkn1cBAC-LacZ (grey—no elevated Cdkn1c expression) progressively increased 
in weight and were not significantly different from one another (n: WT 9, Cdkn1cBACx1 8, 
Cdkn1cBAC-LacZ 10), ** p < 0.01, *** p < 0.001; (b) the food consumption difference between WT, 
Cdkn1cBACx1 and Cdkn1cBAC-LacZ males on a high-fat diet was not found to be significantly different, (n: 
7, 5, 8); (c) Glucose tolerance testing of adult male mice completing a high-fat diet challenge. 
Cdkn1cBACx1 (light green) males were found to possess significantly improved glucose clearance 
compared to WT (black), (n: 9, 8), * p < 0.05; (d) Insulin tolerance testing of adult male mice 
completing a high-fat diet challenge. Cdkn1cBACx1 (light green) males were found to possess 
significantly greater sensitivity to insulin challenge between 30–60 min post injection, (n: 9, 8), * p < 
0.05. 
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Reduced weight in adult mice possessing excess Cdkn1c may, in part,2 be attributed to 
increased brown adipose tissue content, both in the classic interscapular brown adipose depot but 
also within white adipose depots, and therefore elevated mitochondrial uncoupling [23]. In order to 
assess whether the protective phenotype observed in Cdkn1cBACx1 mice challenged with a high-fat 
diet could be attributed to increased BAT content, core temperature was first checked after the 
12-week dietary challenge. Cdkn1cBACx1 males were found to be significantly hotter than wild type 
mice (Figure 3a). Upon culling, the wet weights of selected white adipose depots were found to be 
significantly reduced in the Cdkn1cBACx1 mice (Figure 3b), with epididymal (E) and retroperitoneal 
(R) depots more than 50% smaller than wild type, as a percentage of total body weight. 
Qualitatively, hematoxylin and eosin (H+E) staining revealed differences in white adipocytes 
(Figure 3c) with WT epididymal and anterior sub-cutaneous depots containing predominantly 
larger uni-locular adipocytes relative to the corresponding depots from Cdkn1cBACx1 males, which 
contained areas of multi-locular adipocytes most closely associated with brown adipocytes. In the 
liver, there appeared to be reduced lipid accumulation (white regions) in Cdkn1cBACx1 compared to 
WT samples. We previously reported the increased expression of a number of BAT markers 
downstream of the BAT-determining gene Prdm16 in WAT from young mice, and increased 
PRDM16 protein but not mRNA, suggesting a function for Cdkn1c in the post-transcriptional 
regulation of Prdm16 [23]. QRT-PCR analysis of retroperitoneal adipose tissue revealed a higher 
mRNA expression of mitochondrial uncoupling protein 1 (Ucp-1) and the brown adipose markers 
PGC-1α, Cidea and Elovl3 in Cdkn1cBACx1 retroperitoneal depots relative to WT (Figure 3d). While we 
have not excluded the contribution of other sites of Cdkn1c over-expression to the phenotype, taken 
together, these results are consistent with the increased BAT driven by elevated Cdkn1c dosage 
providing a protective effect against weight gain. 
Recent work has shown that the epigenetic marks which silence the paternal allele of Cdkn1c 
can be disrupted through protein restriction during gestation [17]. Further to this, the stability of 
imprints during aging has recently come into focus, with several reports of altered DNA 
methylation in aged samples [26,27]. We examined Cdkn1c expression in retroperitoneal white 
adipose tissue (R) and interscapular brown adipose tissue (iBAT) in 10-week old WT mice compared 
to 12-month old mice from the same colony. Older mice showed significantly reduced expression of 
Cdkn1c in white adipose and slightly elevated expression in brown adipose tissue compared to 
younger mice (Figure 4a). Two regions of differential methylation (Cdkn1c sDMR and KvDMR) that 
regulate Cdkn1c expression were examined through bisulphite sequencing of genomic DNA from 
the same individuals to try and account for these observed changes in transcription. Methylation of 
the Cdkn1c sDMR and KvDMR in early life adipose tissue has previously been shown to be similar to 
that seen in other tissue [23]. A qualitative analysis of 10-week (left column) and 1-year old (right 
column) wild type retroperitoneal adipose tissue revealed a similar pattern of methylation at both 
Cdkn1c sDMR and the KvDMR (Figure 4b). No gross differences were observed in brown adipose 
tissue (Figure 4c), where expression had been found to be modestly elevated in 1-year old samples 
(Figure 4a). Finally, samples were analyzed from the high-fat diet cohort, with no gross differences 
in methylation detected after 12 weeks of dietary challenge in retroperitoneal tissue (Figure 4d). 
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Figure 3. Cdkn1cBACx1 mice show reduced lipid stores and elevated brown adipose tissue (BAT) 
markers in high-fat diet (HFD)-exposed white adipose tissue. (a) Rectal temperature of adult male 
mice exposed to high-fat diet challenge. Cdkn1cBACx1 males (light green) had a significantly increased 
core body temperature when compared to WT littermates (black), (n: 9, 8), ** p < 0.01; (b) Wet weight 
of white adipose tissue in high-fat diet exposed males, as a percentage of total body weight. 
Mesenteric (M), epididymal (E) and retroperitoneal (R) depots were all found to be significantly 
smaller in Cdkn1cBACx1 males (light green) than WT (black). (n: 9, 8), ** p < 0.01, *** p < 0.001; (c) H+E 
staining of epididymal (top row), anterior sub-cutaneous (Sub Cut, middle row) white adipose and 
liver (bottom row) in WT (left column) and Cdkn1cBACx1 (right column) adult males exposed to 
high-fat diet challenge. Large unilocular cells were consistently observed in WT adipose depots, with 
lipid deposits clearly visible in liver sections. Smaller unilocular and multi-locular adipocytes were 
observed in Cdkn1cBACx1 sections, with sparse lipid deposits in liver sections (scale bar: 20 µm); (d) 
Quantitative RT-PCR analysis of brown adipose markers in retroperitoneal white adipose tissue, 
from adult male mice exposed to a high-fat diet. Significantly elevated markers of brown 
adipogenesis were detected in Cdkn1cBACx1 transcripts when compared to wild type (n: 4, 4). ** p < 
0.01. 
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Figure 4. The Cdkn1c imprint is stable during aging and during post-natal diet challenge. (a) 
Quantitative RT-PCR analysis of Cdkn1c expression changes between 10 weeks and 1 year of age in 
WT adipose depots. A significantly reduced expression of Cdkn1c was detected in aged 
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retroperitoneal (R) adipose tissue, while brown adipose (iBAT) depots were found to possess small 
but significant increases in Cdkn1c expression in aged tissue, (n: 4, 4), * p < 0.05, ** p < 0.01; (b) 
Representative bisulphite sequencing analysis of Cdkn1c sDMR and KvDMR 10-week (left column) 
and 1-year old (right column) retroperitoneal (R) adipose tissue found similar patterns of 
methylation between timepoints in male mice (n: 2, 2) (Filled circles: Methylated CpG, Unfilled 
circles: Un-methylated CpG); (c) Representative bisulphite sequencing analysis of Cdkn1c sDMR and 
KvDMR in 10-week (left column) and 1-year old (right column) iBAT found similar patterns of 
methylation between timepoints in male mice (n: 2, 2); (d) Representative bisulphite sequencing 
analysis of Cdkn1c sDMR and KvDMR control (left column) and high-fat diet fed (right column) 
retroperitoneal adipose tissue (R) methylation, from adult male WT mice. Similar patterns of 
methylation were found between diets (n: 2, 2). 
3. Discussion 
In this study, we show that mice with a single extra copy of Cdkn1c are able to resist both age 
and diet-driven weight gain and maintain a healthier management of glucose than matched 
controls. While we have not defined the mechanism underlying this phenotype, the gains in brown 
adipose tissue that we have shown in younger mice [23], alongside the higher body temperature and 
increased expression of markers of brown fat, suggest that increased thermogenesis may, at least in 
part, play a contributory role. 
Using both loss-of-expression and gain-in-expression animal models, alongside ex-vivo 
approaches, we previously identified an important and intrinsic role for Cdkn1c in the development 
of both classic brown adipose tissue and the brown-like adipose tissue that develops post-natally 
within white adipose depots [23]. We showed that mice with a 2–3-fold elevated expression of 
Cdkn1c possessed substantially more brown adipose tissue and substantially less white adipose 
tissues at 10 weeks of age. In this new study, we show that mice from these same transgenic lines do 
not gain significant weight as they age, unlike their wild type littermates, and this was true for both 
males and females. We also show that these older mice are better able to manage their glucose levels. 
A caveat to this observation is the high blood glucose values relative to other studies on this strain 
background [28]. This may be explained by the standard chow on which we routinely maintain 
mice, Labdiet 5008, which provides a relatively higher proportion of energy from fat and 
carbohydrate compared to other standard chow diets and may induce a diabetic state when fed over 
a prolonged period. An alternative and potentially more interesting explanation is that the WT mice 
were inherently stressed, a factor known to impact blood glucose levels [29]. Higher stress levels in 
the WT littermate controls is suggested by our previous observation that male Cdkn1cBACx1 mice 
disrupt social stability when co-housed with WT mice, resulting in an increased incidence of fighting 
and wounding within these groups [30]. Further studies including single housing animals will be 
required to fully explore these differences.  
We further show that younger mice exposed to a high-fat diet for 12 weeks gain almost no 
weight despite consuming a similar amount of HFD as their WT counterparts under the same 
protocol. As with the older mice, the high-fat diet-exposed Cdkn1c transgenic mice were also better 
able to manage their glucose levels than the controls. Using a control line of mice (Cdkn1cBAC-LacZ) 
which carried the same BAC transgene but without over-expression of Cdkn1c, we were able to 
attribute this weight resistance phenotype to elevated Cdkn1c. Taken together, these data highlight a 
previously unappreciated role for Cdkn1c in weight regulation later in life, at least in mice. The loss 
or gain in function of CDKN1C in humans is already implicated in the childhood growth disorders 
Beckwith-Wiedemann Syndrome, IMAGe syndrome and SRS, recapitulated to some extent in 
animal models. This new data highlights a role for Cdkn1c in regulating adiposity in the adult 
mouse. Quite remarkably, only a two-fold elevation in expression of Cdkn1c was able to protect mice 
against both age and diet-induced weight gain. It should be noted that the changes we observed 
were between 6 months and 1 year of age, which is thought to represent middle age in mice. Our 
analyses did not extend to cover the full aging period. It will be interesting to follow these mice for 
an extended period into old age to ask whether they maintain this metabolic advantage, and 
whether they have an extended lifespan. Further to this, while a reduction in body weight was 
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observed in both genders, a dosage dependent phenotype was not so clearly observed in females. 
Variation in the individual weights of the transgenic groups was larger at 12 months than those 
observed in male mice (Figure 1a, b). It will be important to explore this potential difference between 
genders in a larger cohort over a longer time period.  
The inflexibility of the Cdkn1c imprint to either aging or post-natal diet modification contrasts 
with data seen from in utero exposure [17]. We found that erosion of the Cdkn1c sDMR occurred in 
offspring exposed to gestational low protein diet, with these changes maintained post-natally. Our 
current data would therefore lend support to the hypothesis that altering the dosage of Cdkn1c in 
response to gestational environmental factors can be achieved, but once laid down, this methylation 
is resistant to post-natal adjustment. However, we analyzed DNA methylation in a small number of 
individuals, so we cannot exclude more modest changes in DNA methylation with time or changes 
in other tissues or other strains of mice not analyzed. This stubbornness to change likely provides a 
protective effect in mice, as has been highlighted by the differences in weight observed in our loss of 
imprinting model (Cdkn1cBACx1). A single extra copy of Cdkn1c was sufficient to restrict mice in both 
aging and diet models to only modest weight gain, in addition to the embryonic and post-natal 
growth restriction previously described [20]. In a laboratory setting, such responses would appear 
advantageous. However, outside of food available ad libitum, such excessive uncoupling may in fact 
reduce survival chances, due to the challenges in laying down sufficient adipose stores. By 
restricting changes in imprinted status to an embryonic window, rather than a constant 
environmental sensitivity, this might be prevented. 
Cdkn1c has only recently been identified as having a role in adipose tissue development [23]. 
Interestingly, the response to glucose and insulin tolerance testing in aging mice was found to be 
largely comparable between the Cdkn1cBACx1 and Cdkn1cBACx2 line, whereas whole body and adipose 
depots weights were found to be dosage dependent, with the Cdkn1cBACx2 line having even greater 
reductions. This dosage-based phenotype is also present at early post-natal and fetal time points 
[20]. The lack of a dosage-based phenotype for glucose and insulin tolerance may be attributed to 
simply avoiding the age-related metabolic syndrome that is observed in wild type mice, due to their 
leanness, rather than substantial changes to insulin signaling. However, epigenetic dysregulation at 
the IC2 cluster has previously been demonstrate to affect β-cell mass [31], and therefore a direct role 
cannot be excluded. 
In summary, this is the first report linking Cdkn1c dosage to weight gain in adult mice. Our 
findings, if they translate to humans, have potentially monumental implications for human health. 
In addition to the potential relevance to the rare human disorders that involve either elevated 
expression of Cdkn1c or gain in function mutations of this gene, SRS and IMAGe syndrome [18], 
worldwide obesity has nearly tripled in the last 40 years, resulting in over 650 million obese adults 
and an estimated 41 million children under the age of 5 years being overweight or obese (WHO). 
Unlike many other genes implicated in weight regulation, Cdkn1c is epigenetically regulated. This 
suggests the possibility that epidrugs could be developed that activate the silent Cdkn1c allele with 
therapeutic benefit. Cdkn1c encodes a cyclin-dependent kinase inhibitor and, while we have not 
identified the molecular mechanism through which Cdkn1c drives the development of brown 
adipose, it may be possible to develop designer drugs to mimic this activity. Ultimately, drugs 
aimed at Cdkn1c may provide a way to increase BAT thermogenesis in adult humans to increase 
whole-body energy expenditure and address the global epidemic of obesity. 
4. Materials and Methods 
4.1. Animals and Husbandry 
All animal studies and breeding were approved by the University of Cardiff ethical committee 
and performed under a UK Home Office project license (30/2600 from 4 November 2007 until 4 
November 2013). Mice were housed on a 12 h light–dark cycle with lights coming on at 06.00 h with 
a temperature range of 21 ± 2 °C with free access to tap water and standard chow (Labdiet 5008, 
Labdiet, St. Louis, MO, USA). BAC transgenic lines Cdkn1cBACx1 (previously known as 5D3; single 
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copy of unmodified BAC), Cdkn1cBACx2 (previously known as 5A4; two copies of unmodified BAC) 
and Cdkn1cBAC-LacZ (previously known as 10–10; single copy of modified BAC with no transgenic 
elevation of Cdkn1c) were bred onto a C57BL/6J (BL6) background for >12 generations and 
genotyped as described [21]. For aging studies, mice were group housed and weighed monthly. For 
feeding studies, grouped male mice were transferred onto 58V8 diet (TestDiet, St. Louis, MO, USA) 
for 12 weeks, with weights measured weekly. Core body temperatures of high fat diet mice were 
monitored with a rectal probe (IN005A, Vet-Tech solution, Congleton, UK). 
4.2. Glucose Tolerance Testing 
Mice were fasted overnight, with access to water. All subjects were individually housed for the 
duration of the test, and were weighed before testing began. Tail blood was taken and glucose 
concentration was recorded by Glucose 201+ meter (HemoCue, Ängelholm, Sweden). After samples 
were taken, mice were injected intraperitoneally with 10 mM/ kg (1.8 mg/g) glucose (Sigma Aldrich, 
St. Louis, MO, USA) and further readings were taken at 30, 60, 90 and 120 min post-injection. All 
experiments were performed blind. 
4.3. Insulin Tolerance Testing 
Mice were individually housed with access to food and water. Tail blood was collected and 
glucose concentration was recorded by Glucose 201+ meter (HemoCue, Ängelholm, Sweden). After 
samples were taken, mice were injected intraperitoneally with 0.75 U/ kg insulin (Novo Nordisk 
Bagsvaerd, Denmark) and further readings were taken at 15, 30, 45 and 60 min post-injection. All 
experiments were performed blind. 
4.4. DNA, RNA and H+E Staining Analysis 
Genomic DNA was bisulphite treated using an EZ DNA Methylation Kit (Zymo Research, 
Irvine, CA, USA). Sodium modification treatments were carried out in duplicate for each DNA 
sample and at least three independent amplification experiments were performed for each 
individual examined. The region spanning the Cdkn1c sDMR was amplified by PCR using primers 
5′-tgggtgtagagggtggatttagtta-3′ and 5′-cccacaaaaaccctaccccc-3′ and hemi-nested primer 
5′-gtattgttaggattaggatttagttggtagtagtag-3’. For amplification of KvDMR, the following primers were 
used 5′-taaggtgagtggttttaggat-3′ and 5′-aatcccccacacctaaattc-3′ and hemi-nested primer 
5′-ccactataaacccacacata-3′. TaKaRa EpiTaq™ HS (Takara, Shiga, Japan) was used for PCR 
amplification according to the manufacturer’s specifications. The PCR products were cloned into 
pGEM-T (Promega, Madison, WI, USA) and an average of 20 clones per sample were sequenced 
using M13 reverse primer and an automated ABI Prism 3130xl Genetic Analyzer (Applied 
Biosystems, Foster City, CA, USA) as previously described [16]. Quantitative RT-PCR was 
performed in duplicate on four independent samples as previously described [32]. Briefly, total RNA 
was prepared from tissues using RNA-Bee (AmsBio, Abingdon, UK). cDNA was prepared using 
M-MuLV reverse transcriptase (Roche, Basel, Switzerland) with random hexamers under the 
manufacturers conditions. Quantitative RT-PCR was performed in duplicate on four independent 
samples using DyNAmo HS SYBR Green qPCR kit (Finnzymes, New York, NY, USA) against the 
reference gene β-Actin, and detected using the Chromo 4 Four-Color Real Time detector (MJ 
Research, Reno, NV, USA). H+E staining was performed as previously described [21]. At least three 
samples per experimental group were fixed overnight in phosphate-buffered 4% 
paraformaldehyde, paraffin-embedded and 7 µm sections cut, prior to H&E staining. Images are 
representative of each experimental group. 
4.5. Primers for qRT-PCR 
Cidea F: 5′-tggaaaagggacagaaatgg R: 5′-tctcgtacatcgtggctttg 
PGC-1α F: 5′-tcatcacctaccgttacacctg R: 5′-caagcttctctgagcttccttc 
Elovl3 F: 5′-ctgttgctcatcgttgttgg R: 5′-atctgactacggcgtcatcc 
Int. J. Mol. Sci. 2018, 19, 2734 12 of 13 
 
Cdkn1c F: 5′-agagaactgcgcaggagaac R: 5′-tctggccgttagcctctaaa 
Ucp-1 F: 5′-ggcaaaaacagaaggattgc R: 5′-taagccggctgagatcttgt 
β-Actin F: 5′-cctgtatgcctctggtcgta R: 5′-ccatctcctgctcgaagtct 
4.6. Statistical Analyses 
Statistical significance (probability values) was determined using the Student’s t-test 
(two-tailed distribution and two sample unequal variance). For quantitative RT-PCR analysis, the 
Mann-Whitney test was performed on ΔCt values between groups. 
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